Mortimer Ian's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Jan 27, 2025
- Accession no.
- 0000950170-25-009388
- Filed
- Jan 27, 2025
- Trade date
- Jan 23-27, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.21M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mortimer IanCIK 0001619961 | Director, Officer (PRESIDENT & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Common Shares | MOption exerciseAcquired | +16,217 | $17.76 | +$288,013.92 | 47,519 | Direct | |
| Jan 23, 2025 | Common Shares | SSaleDisposed | −16,217 | $40.08 | −$649,977.36 | 31,302 | Direct | |
| Jan 24, 2025 | Common Shares | MOption exerciseAcquired | +22,468 | $17.76 | +$399,031.68 | 53,770 | Direct | |
| Jan 24, 2025 | Common Shares | SSaleDisposed | −22,468 | $40.20 | −$903,213.6 | 31,302 | Direct | |
| Jan 27, 2025 | Common Shares | MOption exerciseAcquired | +15,166 | $17.76 | +$269,348.16 | 46,468 | Direct | |
| Jan 27, 2025 | Common Shares | SSaleDisposed | −15,166 | $40.46 | −$613,616.36 | 31,302 | Direct | |
| Jan 27, 2025 | Common Shares | MOption exerciseAcquired | +1,149 | $17.76 | +$20,406.24 | 32,451 | Direct | |
| Jan 27, 2025 | Common Shares | SSaleDisposed | −1,149 | $41.07 | −$47,189.43 | 31,302 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Common Shares | MOption exerciseDisposed | −16,217 | $0.00 | $0 | 38,783 | Direct | |
| Jan 24, 2025 | Common Shares | MOption exerciseDisposed | −22,468 | $0.00 | $0 | 16,315 | Direct | |
| Jan 27, 2025 | Common Shares | MOption exerciseDisposed | −16,315 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.